Tactile Systems Technology Insider Trades
NASDAQ: TCMDHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 12 · $2.02M
- Shares bought / sold
- 0 / 70.89K
- Net activity
- Net selling $2.0 million
Tactile Systems Technology insider activity
Over the last 12 months, Tactile Systems Technology insiders reported 32 transactions on SEC Form 4: 0 open-market purchases and 12 sales. Insiders bought $0 and sold $2.0 million worth of stock, for net insider selling of $2.0 million. The largest seller was Dodd Sheri Louise, with $1.1 million in reported sales.
The most recent filing shows Dodd Sheri Louise (Chief Executive Officer) selling 10,978 shares at $29.44 on Aug 10, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TCMD's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
TCMD insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 10, 2026 | Dodd Sheri LouiseChief Executive Officer | Sale | 10,978 | $323.24K | Form 4 |
| May 11, 2026 | Birkemeyer Elaine M.CHIEF FINANCIAL OFFICER | Sale | 4,631 | $113.40K | Form 4 |
| May 6, 2026 | Shafer David BrentDirector | Award | 6,521 | — | Form 4 |
| May 6, 2026 | Pearson AndreaDirector | Award | 6,521 | — | Form 4 |
| May 6, 2026 | King Laura G.Director | Award | 6,521 | — | Form 4 |
| May 6, 2026 | BURKE WILLIAM WDirector | Award | 6,521 | — | Form 4 |
| May 6, 2026 | Washington Boyd VindellDirector | Award | 6,521 | — | Form 4 |
| May 6, 2026 | Volkart Carmen BDirector | Award | 6,521 | — | Form 4 |
| May 6, 2026 | Huggenberger RaymondDirector | Award | 6,521 | — | Form 4 |
| May 6, 2026 | Asbury Valerie L.Director | Award | 6,521 | — | Form 4 |
| Mar 9, 2026 | Pearson AndreaDirector | Award | 852 | — | Form 4 |
| Feb 24, 2026 | Birkemeyer Elaine M.CHIEF FINANCIAL OFFICER | Sale | 7,701 | $222.88K | Form 4 |
| Feb 24, 2026 | Burns KristieSr. VP Mktg & Clinical Affairs | Sale | 6,246 | $180.76K | Form 4 |
| Feb 24, 2026 | Dodd Sheri LouiseChief Executive Officer | Sale | 10,993 | $318.14K | Form 4 |
| Feb 23, 2026 | Burns KristieSr. VP Mktg & Clinical Affairs | Sale | 160 | $4.59K | Form 4 |
| Feb 23, 2026 | Burns KristieSr. VP Mktg & Clinical Affairs | Sale | 4,279 | $121.02K | Form 4 |
| Feb 23, 2026 | Dodd Sheri LouiseChief Executive Officer | Sale | 537 | $15.41K | Form 4 |
| Feb 23, 2026 | Dodd Sheri LouiseChief Executive Officer | Sale | 14,703 | $415.84K | Form 4 |
| Feb 23, 2026 | Birkemeyer Elaine M.CHIEF FINANCIAL OFFICER | Sale | 196 | $5.62K | Form 4 |
| Feb 23, 2026 | Birkemeyer Elaine M.CHIEF FINANCIAL OFFICER | Sale | 5,322 | $150.52K | Form 4 |
| Feb 20, 2026 | Burns KristieSr. VP Mktg & Clinical Affairs | Award | 7,123 | — | Form 4 |
| Feb 20, 2026 | Burns KristieSr. VP Mktg & Clinical Affairs | Award | 4,058 | — | Form 4 |
| Feb 20, 2026 | Burns KristieSr. VP Mktg & Clinical Affairs | Award | 3,490 | — | Form 4 |
| Feb 20, 2026 | Dodd Sheri LouiseChief Executive Officer | Award | 28,216 | — | Form 4 |
| Feb 20, 2026 | Dodd Sheri LouiseChief Executive Officer | Award | 19,751 | — | Form 4 |
| Feb 20, 2026 | Birkemeyer Elaine M.CHIEF FINANCIAL OFFICER | Award | 15,575 | — | Form 4 |
| Feb 20, 2026 | Birkemeyer Elaine M.CHIEF FINANCIAL OFFICER | Award | 6,765 | — | Form 4 |
| Feb 20, 2026 | Birkemeyer Elaine M.CHIEF FINANCIAL OFFICER | Award | 3,579 | — | Form 4 |
| Feb 19, 2026 | Birkemeyer Elaine M.CHIEF FINANCIAL OFFICER | Award | 23,008 | — | Form 4 |
| Feb 19, 2026 | Burns KristieSr. VP Mktg & Clinical Affairs | Award | 6,194 | — | Form 4 |
| Feb 19, 2026 | Dodd Sheri LouiseChief Executive Officer | Award | 48,672 | — | Form 4 |
| Jan 2, 2026 | Burns KristieSr. VP Mktg & Clinical Affairs | Sale | 5,139 | $148.26K | Form 4 |
| Aug 8, 2025 | Dodd Sheri LouiseChief Executive Officer | Sale | 7,762 | $95.91K | Form 4 |
| May 12, 2025 | Birkemeyer Elaine M.Chief Financial Officer | Sale | 2,921 | $29.04K | Form 4 |
| May 8, 2025 | BURKE WILLIAM WDirector | Sale | 3,300 | $31.91K | Form 4 |
| May 8, 2025 | Dodd Sheri LouiseChief Executive Officer | Sale | 3,149 | $30.95K | Form 4 |
| May 7, 2025 | Washington Boyd VindellDirector | Award | 16,078 | — | Form 4 |
| May 7, 2025 | Volkart Carmen BDirector | Award | 16,078 | — | Form 4 |
| May 7, 2025 | Shafer David BrentDirector | Award | 16,078 | — | Form 4 |
| May 7, 2025 | King Laura G.Director | Award | 16,078 | — | Form 4 |
| May 7, 2025 | Huggenberger RaymondDirector | Award | 16,078 | — | Form 4 |
| May 7, 2025 | Asbury Valerie L.Director | Award | 16,078 | — | Form 4 |
| May 7, 2025 | BURKE WILLIAM WDirector | Award | 16,078 | — | Form 4 |
| Mar 11, 2025 | REUVERS DANIEL L.Director | Gift | 68,162 | — | Form 4 |
| Mar 11, 2025 | REUVERS DANIEL L.Director | Gift | 68,162 | — | Form 4 |
| Feb 25, 2025 | REUVERS DANIEL L.Director | Sale | 28,338 | $401.85K | Form 4 |
| Feb 25, 2025 | Burns KristieSr. VP Mktg & Clinical Affairs | Sale | 6,468 | $93.16K | Form 4 |
| Feb 25, 2025 | Birkemeyer Elaine M.Chief Financial Officer | Sale | 2,066 | $29.98K | Form 4 |
| Feb 24, 2025 | Birkemeyer Elaine M.Chief Financial Officer | Sale | 3,778 | $55.54K | Form 4 |
| Feb 24, 2025 | Burns KristieSr. VP Mktg & Clinical Affairs | Sale | 4,830 | $70.75K | Form 4 |
| Feb 24, 2025 | REUVERS DANIEL L.Director | Sale | 10,938 | $159.15K | Form 4 |
| Feb 20, 2025 | Dodd Sheri LouiseChief Executive Officer | Award | 65,669 | — | Form 4 |
| Feb 20, 2025 | Dodd Sheri LouiseChief Executive Officer | Award | 20,108 | — | Form 4 |
| Feb 20, 2025 | King Laura G.Director | Award | 2,970 | — | Form 4 |
| Feb 20, 2025 | Birkemeyer Elaine M.Chief Financial Officer | Award | 36,248 | — | Form 4 |
| Feb 20, 2025 | Birkemeyer Elaine M.Chief Financial Officer | Award | 6,887 | — | Form 4 |
| Feb 20, 2025 | Birkemeyer Elaine M.Chief Financial Officer | Award | 3,446 | — | Form 4 |
| Feb 20, 2025 | Burns KristieSr. VP Mktg & Clinical Affairs | Award | 16,579 | — | Form 4 |
| Feb 20, 2025 | Burns KristieSr. VP Mktg & Clinical Affairs | Award | 4,131 | — | Form 4 |
| Feb 20, 2025 | Burns KristieSr. VP Mktg & Clinical Affairs | Award | 3,359 | — | Form 4 |
| Feb 20, 2025 | REUVERS DANIEL L.Director | Award | 15,853 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4